Achieve Life Sciences: The Recent Sell Off Skews The Outcomes [Seeking Alpha]
Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability
Achieve Life Sciences (ACHV) had its "buy" rating reaffirmed by HC Wainwright. They now have a $12.00 price target on the stock.
Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]
Achieve Life Sciences, Inc. (ACHV) Q4 2025 Earnings Call Transcript [Seeking Alpha]